The Genetic Aspects of Periodontitis Pathogenesis and the Regenerative Properties of Stem Cells

Klaudia Ustianowska,Łukasz Ustianowski,Estera Bakinowska,Kajetan Kiełbowski,Joanna Szostak,Martyna Murawka,Bartosz Szostak,Andrzej Pawlik
DOI: https://doi.org/10.3390/cells13020117
IF: 6
2024-01-10
Cells
Abstract:Periodontitis (PD) is a prevalent and chronic inflammatory disease with a complex pathogenesis, and it is associated with the presence of specific pathogens, such as Porphyromonas gingivalis. Dysbiosis and dysregulated immune responses ultimately lead to chronic inflammation as well as tooth and alveolar bone loss. Multiple studies have demonstrated that genetic polymorphisms may increase the susceptibility to PD. Furthermore, gene expression is modulated by various epigenetic mechanisms, such as DNA methylation, histone modifications, or the activity of non-coding RNA. These processes can also be induced by PD-associated pathogens. In this review, we try to summarize the genetic processes that are implicated in the pathogenesis of PD. Furthermore, we discuss the use of these mechanisms in diagnosis and therapeutic purposes. Importantly, novel treatment methods that could promote tissue regeneration are greatly needed in PD. In this paper, we also demonstrate current evidence on the potential use of stem cells and extracellular vesicles to stimulate tissue regeneration and suppress inflammation. The understanding of the molecular mechanisms involved in the pathogenesis of PD, as well as the impact of PD-associated bacteria and stem cells in these processes, may enhance future research and ultimately improve long-term treatment outcomes.
cell biology
What problem does this paper attempt to address?
The paper attempts to address two main issues: 1. **Genetic mechanisms of Periodontitis (PD)**: The paper discusses in detail the gene polymorphisms associated with susceptibility to periodontitis and their roles in the disease's occurrence. Specifically, the researchers summarize various gene polymorphisms related to periodontitis susceptibility, including antimicrobial peptides (such as β-defensin, lactoferrin, LL-37), cytokines (such as interleukin-1, interleukin-17), prostaglandin-endoperoxide synthase 2 (COX-2), matrix metalloproteinases (MMPs), CD14 molecules, Toll-like receptors (TLRs), human leukocyte antigen (HLA), antibodies (Ig), and antibody Fc fragment receptors (FcR). 2. **Application of stem cells and extracellular vesicles in the treatment of periodontitis**: The paper also discusses the potential applications of stem cells and extracellular vesicles in promoting periodontal tissue regeneration and inhibiting inflammation. The researchers summarize the current evidence on these novel therapeutic methods, highlighting their potential in improving the long-term treatment outcomes of periodontitis. Overall, the paper aims to provide new insights and methods for the diagnosis and treatment of periodontitis by summarizing genetic and epigenetic mechanisms and exploring the applications of stem cells and extracellular vesicles.